EUVIMEDEUVIMED entdecken
Fallbericht

Extranodal NK/T-cell lymphoma, nasal type: a case report

Ghadah K. Al Fraihi, Bassam Alghamdi, Abdullah Alkhaldi, Saleh K. Alqaryan, Abdulrahman Alfayez, Abeer R. Alomaish, Leena Taher

AME Case Reports · 2026-11 · 10 · 231-231

DOI: 10.21037/acr-2026-0147 ↗

Kurz gefasst

Fallbericht in der Zeitschrift AME Case Reports, 2026-11. Verfasst von Ghadah K. Al Fraihi und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Extranodal NK/T-cell lymphoma, nasal type (ENKTL-NT), is a rare, aggressive Epstein-Barr virus (EBV)-associated lymphoma that can mimic chronic rhinosinusitis. This report aims to emphasize case-specific diagnostic red flags, provide complete staging and risk stratification, and describe the contemporary combined-modality treatment course.Case Description: A 45-year-old man presented with 2 months of progressive unilateral nasal obstruction, recurrent infections, fever, 9-kg weight loss, and night sweats despite multiple antibiotic and topical regimens. Computed tomography (CT) showed extensive left-sided sinonasal opacification. During functional endoscopic sinus surgery (FESS), the sinonasal mucosa was necrotic, pale, poorly vascularized, and bled minimally during debridement. Histopathology demonstrated angiocentric and angiodestructive atypical lymphoid infiltration with necrosis; tumor cells expressed CD2, cytoplasmic CD3epsilon, CD56, granzyme B, and EBV-encoded RNA (EBER), with a Ki-67 index of approximately 80%. Pretreatment positron emission tomography (PET)/CT showed an intensely hypermetabolic sinonasal lesion extending to the nasopharynx [maximum standardized uptake value (SUVmax), 31.8], without significant nodal or distant disease; bone marrow biopsy was negative. The disease was Ann Arbor stage IE, with an Eastern Cooperative Oncology Group (ECOG) performance status of 0, elevated pretreatment lactate dehydrogenase (LDH) (330 U/L; reference range, 125–220 U/L), plasma EBV DNA of 599 IU/mL, prognostic index of natural killer lymphoma (PINK) score of 0, and PINK with EBV DNA (PINK-E) score of 1 (both low risk). He completed six cycles of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) using a sandwich approach with volumetric-modulated arc radiotherapy (54 Gy in 30 fractions). Acute radiotherapy effects were limited to mild erythema, mucositis, and oropharyngeal candidiasis treated with nystatin. End-of-treatment PET/CT on 9 March 2026 demonstrated metabolic remission.

Conclusions

Persistent unilateral sinonasal disease that is refractory to treatment, particularly when accompanied by constitutional symptoms and necrotic avascular tissue with minimal operative bleeding, should prompt early, adequately sampled biopsy. Complete staging, EBV DNA assessment, and multidisciplinary asparaginase-based chemoradiotherapy are central to management.

Zitieren

APA

Fraihi, G. K. A., Alghamdi, B., Alkhaldi, A., Alqaryan, S. K., Alfayez, A., Alomaish, A. R., & Taher, L. (2026). Extranodal NK/T-cell lymphoma, nasal type: a case report. AME Case Reports, 10, 231-231. https://doi.org/10.21037/acr-2026-0147

Vancouver

Fraihi GKA, Alghamdi B, Alkhaldi A, Alqaryan SK, Alfayez A, Alomaish AR, et al. Extranodal NK/T-cell lymphoma, nasal type: a case report. AME Case Reports. 2026;10:231-231. doi:10.21037/acr-2026-0147

BibTeX
@article{Fraihi2026,
  author = {Fraihi, Ghadah K. Al and Alghamdi, Bassam and Alkhaldi, Abdullah and Alqaryan, Saleh K. and Alfayez, Abdulrahman and Alomaish, Abeer R. and Taher, Leena},
  title = {Extranodal NK/T-cell lymphoma, nasal type: a case report},
  journal = {AME Case Reports},
  year = {2026},
  volume = {10},
  pages = {231--231},
  doi = {10.21037/acr-2026-0147}
}
Kostenlos starten →